> top > docs > PMC:7736111 > spans > 58204-59139 > annotations

PMC:7736111 / 58204-59139 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T14 218-242 Phenotype denotes interstitial pneumonitis http://purl.obolibrary.org/obo/HP_0006515

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1539 64-67 Gene denotes CD4 Gene:920
1540 159-162 Gene denotes CD4 Gene:920
1541 809-812 Gene denotes CD4 Gene:920
1542 820-823 Gene denotes CD8 Gene:925
1543 489-492 Gene denotes CD4 Gene:920
1544 498-501 Gene denotes CD8 Gene:925
1545 346-349 Gene denotes CD8 Gene:925
1546 337-340 Gene denotes CD4 Gene:920
1547 78-86 Species denotes SARS-CoV Tax:694009
1548 528-536 Species denotes patients Tax:9606
1549 231-242 Disease denotes pneumonitis MESH:D011014
1550 660-678 Disease denotes SARS-CoV infection MESH:C000657245
1551 879-897 Disease denotes SARS-CoV infection MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T336 0-141 Sentence denotes Animal studies have revealed the critical molecular insights of CD4+ cells in SARS-CoV clearance and attenuation of a pathological condition.
T337 142-281 Sentence denotes The depletion of CD4+ cells was associated with reduced virus clearance and interstitial pneumonitis (Jin et al., 2005; Wang et al., 2006).
T338 282-407 Sentence denotes In comparison, the adoptive transfer of virus-specific CD4+ and CD8+ T cells resulted in viral clearance (Zhao et al., 2010).
T339 408-624 Sentence denotes Similarly, clinical data has consistently shown the presence of antigen-specific CD4+ and CD8+ T cells in the recovered patients, akin to what was found in immunized animals, reviewed in Channappanavar et al. (2014).
T340 625-761 Sentence denotes On the other hand, severe cases of SARS-CoV infection were associated with a decline in T cells, as will be discussed in later sections.
T341 762-935 Sentence denotes Thus, based on these animal and clinical data, CD4+ T and CD8+ T cells were central to the antiviral response during SARS-CoV infection (Peng et al., 2006; Oh et al., 2012).